Bortezomib for the treatment of multiple myeloma: Cochrane systematic review
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Bortezomib for the Treatment of Multiple Myeloma: Cochrane Systematic Review." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/439790/all/images/ios-appstore-badge.png. Accessed 27 April 2024.
Bortezomib for the treatment of multiple myeloma: Cochrane systematic review. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439790/all/images/ios-appstore-badge.png. Accessed April 27, 2024.
Bortezomib for the treatment of multiple myeloma: Cochrane systematic review. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/439790/all/images/ios-appstore-badge.png
Bortezomib for the Treatment of Multiple Myeloma: Cochrane Systematic Review [Internet]. In: Cochrane Abstracts. [cited 2024 April 27]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/439790/all/images/ios-appstore-badge.png.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Bortezomib for the treatment of multiple myeloma: Cochrane systematic review
ID - 439790
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/439790/all/images/ios-appstore-badge.png
DB - Evidence Central
DP - Unbound Medicine
ER -